1. Cleary P. The FDA selects the development of an artificial pancreas as a critical path opportunity: JDRF praises the FDA for supporting technology that will revolutionize diabetes care. Juvenile Diabetes Research Foundation International Web site. Available at: http://www.jdrf.org/index.cfm? page_id=104778. Accessed April 27, 2006.
2. Tavris DR, Shoaibi A. The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)—an assessment of the literature.Diabetes Technol Ther. 2004; 6: 518–522.
3. Bode B, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo and hyperglycemia: the Guardian Continuous Monitoring System.Diabetes Technol Ther. 2004; 6: 105–113.
4. US Food and Drug Administration. Guardian RT—P980022s011. FDA, Center for Devices and Radiological Health Web site. Available at: http://www.fda.gov/cdrh/pdf/p980022s011.html. Accessed April 27, 2006.
5. Medtronic, Inc. Web site. Medtronic receives FDA approval for the world’s first insulin pump with real-time continuous glucose monitoring. Available at: http://wwwp.medtronic.com/ Newsroom/NewsReleaseDetails.do?itemId=1144875806140&lang=en_US. Accessed April 27, 2006.